Boster Biological Technology

Anti-PD-L1/CD274 Antibody (Clone#IDC-3)

#BM4816 · western blot

3
Citing papers
44
Combined citations
Supplier page Find this product

Research areas

Ferroptosis and cancer prognosis2Cancer, Hypoxia, and Metabolism1Cancer Immunotherapy and Biomarkers1Bladder and Urothelial Cancer Treatments1MicroRNA in disease regulation1Renal cell carcinoma treatment1Circular RNAs in diseases1

Papers citing this product

1
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma
Journal for ImmunoTherapy of Cancer·2024·21 cit.·DOI
2
IGF2BP3 overexpression predicts poor prognosis and correlates with immune infiltration in bladder cancer
BMC Cancer·2023·20 cit.·DOI
3
Identification of circRNAs involved in the development of hepatocellular carcinoma after insufficient radiofrequency ablation
Neoplasma·2022·3 cit.·DOI

Similar products

ProductVendorPricePapers
PD-L1/CD274RabbitProteintech$140200
PD-L1/CD274RabbitProteintech$195200
PD-L1/CD274RabbitProteintech$267200
PD-L1/CD274RabbitProteintech$116200
PD-L1/CD274RabbitProteintech$158200
PD-L1/CD274RabbitProteintech$250200
PD-L1/CD274RabbitProteintech$267200
PD-L1/CD274RabbitProteintech$190200
PD-L1/CD274RabbitProteintech$210200